UPLOAD Filing
Annovis Bio, Inc.
Date: Sept. 30, 2025 · CIK: 0001477845 · Accession: 0000000000-25-010718
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-39202
Letter
Re: Annovis Bio, Inc. Form 10-K for the fiscal year ended December 31, 2024 Filed March 21, 2025 File No. 001-39202 Dear Maria Maccecchini:
September 30, 2025
Maria Maccecchini President, Chief Executive Officer and Acting Chief Financial Officer Annovis Bio, Inc. 101 Lindenwood Drive, Suite 225 Malvern, PA 19355
We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> September 30, 2025 Maria Maccecchini President, Chief Executive Officer and Acting Chief Financial Officer Annovis Bio, Inc. 101 Lindenwood Drive, Suite 225 Malvern, PA 19355 Re: Annovis Bio, Inc. Form 10-K for the fiscal year ended December 31, 2024 Filed March 21, 2025 File No. 001-39202 Dear Maria Maccecchini: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences </TEXT> </DOCUMENT>